STRATUS CS TROPONIN I CALIBRATOR

K983722 · Dade Behring, Inc. · JIT · Nov 4, 1998 · Clinical Chemistry

Device Facts

• Record ID: K983722
• Device Name: STRATUS CS TROPONIN I CALIBRATOR
• Applicant: Dade Behring, Inc.
• Product Code: JIT · Clinical Chemistry
• Decision Date: Nov 4, 1998
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 862.1150
• Device Class: Class 2

Intended Use

The Cardiac Troponin-I Calibrator (TROP CalPak) is intended to be used to calibrate the Cardiac Troponin I method on the Stratus® CS analyzer.

Device Story

Stratus® CS Troponin I Calibrator (TROP CalPak) is a single-use plastic cartridge containing buffered bovine protein with native human troponin complex. It serves as a secondary calibrator for the Cardiac Troponin I assay on the Stratus® CS analyzer. The device is used in clinical laboratory settings by laboratory personnel to establish calibration curves for the analyzer, ensuring accurate measurement of cardiac troponin I levels in patient samples. By providing a known concentration of native human troponin complex, the calibrator allows the analyzer to translate raw signal data into clinically relevant analyte concentrations, supporting the diagnosis and management of cardiac conditions.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Single-use plastic cartridge containing buffered bovine protein matrix and native human troponin complex. Concentration: 40 ng/mL. Form: Frozen. Intended for use as a secondary calibrator for the Stratus® CS analyzer.

Indications for Use

Indicated for use as a calibrator for the Cardiac Troponin I method on the Stratus® CS analyzer.

Regulatory Classification

Identification

A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)

Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

Predicate Devices

• Stratus® CS TROP CalPak (K981100)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows a sequence of handwritten digits and a letter. The sequence starts with the letter 'K', followed by the digits '4', '8', '3', '7', and '2'. The digits are written in a connected manner, resembling cursive handwriting. The image appears to be a close-up of the handwritten sequence.

Image /page/0/Picture/1 description: The image shows the text "NOV 4 1998". The text is in a bold, sans-serif font. The letters and numbers are all black. The background is white.

DADE BEHRING INC. P.O. Box 6101 Newark, DE 19714

# Dade Behring

## Summary of Safety and Effectiveness Information

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

| Submitter's Name: | Rebecca S. Ayash<br>Dade Behring Inc.<br>Building 500, Mailbox 514<br>P.O. Box 6101<br>Newark, DE 19714-6101<br>Phone: [phone]<br>FAX: [phone] |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Date of Preparation: | 10/21/98 |
| Device Name: | Stratus® CS Troponin I Calibrator (TROP CalPak) |
| Classification Name: | Calibrator, secondary |
| Predicate Device: | Stratus® CS TROP CalPak (K981100) |

Device Description: The Stratus® CS TROP CalPak is a plastic cartridge which contains buffered bovine protein with native human troponin complex in three of the reagent wells. The approximate concentration of troponin complex per well is 40 ng/mL. The CalPak is a single-use product.

Intended Use: The TROP CalPak is intended to be used for calibration of the Cardiac Troponin I method on the Stratus® CS analyzer.

#### Comparison to Predicate Device:

| | Stratus® CS TROP CalPak<br>(Modified) | Stratus® CS TROP CalPak<br>(K981100) |
|-------------------------|---------------------------------------|--------------------------------------|
| Intended Use | Calibrator | Calibrator |
| Analyte | Native human troponin complex | Troponin-I peptide fragment |
| Matrix | Buffered bovine protein | Buffered bovine protein |
| Form | Frozen | Frozen |
| Target Concentration | 40 ng/mL | 45 ng/mL |
| Values | Assigned | Assigned |
| Packaging Configuration | Single use plastic cartridge | Single use plastic cartridge |
| Levels | One | One |

{1}------------------------------------------------

Comments on Substantial Equivalence: The Stratus® CS TROP CalPak (modified) is equivalent to the Stratus® CS TROP CalPak currently marketed. Both products are manufactured using a buffered bovine protein matrix but differ in analyte source. Both products are intended to be used as calibrators for the Stratus® CS Cardiac Troponin I method.

Conclusion: The modified Stratus® CS TROP CalPak is substantially equivalent to the Stratus® CS TROP CalPak currently marketed by Dade Behring based on the companson summarized above.

Rebecca S. Ayash

Rebecca S. Ayash Regulatory Affairs and Compliance Manager Date: 10/21/98

{2}------------------------------------------------

Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread.

#### NOV 4 1998

Ms. Rebecca S. Ayash Requlatory Affairs and Compliance Manager DADE BEHRING, INC. Building 500, Mailbox 514 P.O. Box 6101 Newark, Delaware 19714-6101

Re : K983722 Trade Name: Stratus® CS Troponin-I Calibrator (TROP CalPak) Requlatory Class: II Product Code: JIT Dated: October 21, 1998 Received: October 21, 1998

Dear Ms. Ayash:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

{3}------------------------------------------------

Page 2

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Steven Sutman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radioloqical Health

Enclosure

.İ.

{4}------------------------------------------------

### Indications Statement

Device Name: Stratus® CS Troponin I Calibrator (TROP CalPak)

Indications for Use: The Cardiac Troponin-I Calibrator (TROP CalPak) is intended to be used to calibrate the Cardiac Troponin I method on the Stratus® CS analyzer.

Rebecca S. Ayash

Rebecca S. Ayas Regulatory Affairs and Compliance Manager Date: 10/21/98

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

K983722
510(k) Number

signature

Division Sign-Off Office of Device Evaluation

ﻪ،ﺳﻪ

/ prescription use